Event Participants
Executives
4
Aarti Jhunjhunwala, Arindam Choudhuri, Sanjay Tibrewala, Yusuf K Contractor
Analysts
11
Akhilesh Pathak, Hardik, Kriti Tripathi, Parth Modi, Prateek Giri, Rohit Ohri, Rushil Shah, Samarth Goel, Sunil Jain, Utkarsh Somaiya, Vignesh Iyer
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Income | ₹386.72 crores | +165% YoY vs ₹146.62 crores; driven by full-quarter contribution from CrudeChem (US) operations plus healthy domestic growth |
| Gross Profit | ₹133.4 crores | +190% YoY vs ₹45.96 crores; gross margin 35.42%, up from ~33% YoY and ~29–30% last quarter, aided by raw material pass-through |
| EBITDA | ₹59.14 crores | +134.7% YoY vs ₹25.2 crores; EBITDA margin 15.70%, up ~150 bps QoQ from 13.93% |
| Profit After Tax | ₹48.21 crores | +92.67% YoY vs ₹25.03 crores |
| ROIC | 33.06% | Sustained high returns reflecting specialty-chemicals, low-capex business model |
| ROCE | 25.56% | Consistent with 60-quarter track record of healthy capital efficiency |
| ROE | ~20% | |
| Working Capital Cycle | 72 days | Reflects disciplined capital management while scaling international operations |
| Texas Manufacturing Capacity | 148,000 MTPA | Expanded from 80,000 MTPA (+69,000 MTPA) during Q1; total company capacity now 268,000 MTPA |
| Texas Capacity Utilization | 63% | On one-shift basis of 148,000 MTPA; management sees 30–40% revenue headroom on existing capacity |
| Export Mix | 77% | Up from 70%; includes all non-India sales (Malaysia, USA operations) |
| Dealer Network | 115 | Up from 103; predominantly Fineotex India standalone, as US business is direct-to-end-user |
Geographic & Segment Commentary
Oil & Gas Speciality Chemicals (CrudeChem, US): Contributing
65% of consolidated revenue (₹250 crores in Q1) and ~55% of volume; Texas capacity expanded to 148,000 MTPA during the quarter, currently 63% utilized on one shift. Operational efficiency, procurement synergies and green chemistry product demand have driven meaningful EBITDA margin expansion, strengthening competitive positioning in North American oilfield chemicals.Textile Specialty Chemicals (India & International): Resilient but flattish Q1 (₹132 crores vs ₹137 crores Q1 FY26), with the dip termed optical/minor and seasonal — Q1 monsoon softness, competitive intensity, and product mix shift toward FSPL Specialties (100% subsidiary under 115BAB tax regime). Demand supported by improving exports, healthy domestic consumption, and rising sustainability requirements; R&D focused on pre-treatment, dyeing, finishing, and technical textiles (automotive, medical, industrial).
International (Malaysia & Other): Products serve customers across 70+ countries; Malaysian plant (72% owned) also contributing to the international revenue classification alongside US operations. Canada sales commenced last month; Middle East (Saudi) order wins and Suriname/Guyana opportunities being pursued.
Company-Specific & Strategic Commentary
US Capacity Expansion: Commissioned major expansion at Texas facility during Q1, increasing capacity to ~148,000 MTPA (from 80,000 MTPA), enabling larger customer contracts and participation in bigger commercial opportunities alongside the strategically located Midland facility.
CrudeChem Integration & Synergies: Technology transfer, cross-selling with existing Fineotex customers, improved supplier pricing post capital infusion, and last-mile delivery capability (Trackmax subsidiary) driving margin gains; customers include top global service operators (Shell, ExxonMobil, Halliburton). Saudi order won where customer's USD 8 billion Aramco order uses Fineotex specialty packages.
Diversification Strategy: Evolved from textile-only to oil & gas, water treatment, industrial/institutional cleaning, construction chemicals, paints, and performance chemicals; 65% of revenue now from oil & gas, reducing textile concentration risk.
Disciplined M&A Approach: Two acquisitions to date — Malaysian specialty chemicals entity (Aug 2011, 72% owned) and CrudeChem Group (Dec 9, 2025); criteria remain synergy and value creation, with deal pipeline being evaluated and exchanges to be informed at advanced stage.
India Structure & Tax Optimization: New plant housed under FSPL Specialties (100% subsidiary, commissioned August 2025) qualifying for 115BAB concessional 15% tax rate; India standalone dip is optical — combined FCL + FSPL shows no decline.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| CrudeChem (Oil & Gas) Revenue | USD 100 million in FY27; USD 200 million in FY28 | Q1 run-rate (~₹250 crores/quarter ≈ USD 100 million annualized) supports FY27 target; based on order book and customer engagements, not crude price assumptions |
| Texas Capacity Utilization | Full utilization targeted in "coming few quarters" | Currently 63% on one shift; incremental revenue of 30–40% achievable on existing capacity; additional capex minimal (USD 1–2 million) if needed |
| Consolidated Revenue Base | Q1 FY27 as base quarter | Management expects Q1 FY27 to serve as the base quarter going forward in terms of capacity utilization and revenue |
| EBITDA Margin | Aspiration toward 18% (analyst-referenced) | Management avoids fixed margin guidance due to multi-product basket; blended margins sustainable with pass-through pricing |
| Textile Business Growth | Improvement expected in coming quarters | Bangladesh team expansion, trade fair participation, Bharat Tex opportunities; recovery from monsoon-seasonal Q1 softness |
Risks & Constraints
| Risk | Context |
|---|---|
| Raw Material Volatility / Geopolitics | Middle East conflict caused input cost fluctuation during Q1; management passed on increases via pricing and US "war surcharge" mechanism, preserving margins — but volatility remains a recurring uncertainty |
| Crude Oil Price Fluctuations | Management argues oil & gas chemical demand is not directly tied to crude levels (production investments committed years ahead); however, meaningfully lower crude (sub-USD 60) could dampen US activity levels |
| Indian Textile Competition & Tariffs | Intense competition in domestic textile chemicals persisted; tariff impacts from the last 16–18 months are easing with UK/EU/US trade agreements, but recovery is gradual and Q1 monsoon seasonality weighs on expensive performance products |
| Freight Cost Volatility | Geopolitical disruptions cause freight cost swings; managed through surcharge pass-through mechanisms, though impact varies by product and region |
| Integration & Ramp-up Execution | Scaling US operations involves new manpower, R&D costs, and capacity absorption; management expects full utilization in coming quarters but timetable is not committed |
Q&A Highlights
Capacity Expansion & Growth Trajectory
- Question: With Texas capacity expanded from 80,000 to 148,000 MTPA (total 268,000 MTPA), what revenue/profit growth can be expected? Any specific inorganic opportunities and timeline? (Kriti Tripathi, NVS Brokerage)
- Answer: Q1 FY27 should be a base quarter going forward; Texas is only 63% utilized, leaving 30–40% revenue headroom. Oil & gas contributes ~65% of revenue and ~55% of volume. On M&A: disciplined approach with synergy plus value criteria; deals evaluated continuously, exchanges notified only at advanced stage. CrudeChem was a "perfect synergy" — Fineotex provided growth capital to take the business to the next level. (Sanjay Tibrewala)
Oil & Gas Revenue Guidance — Crude Price Sensitivity
- Question: Is the USD 100 million FY27 / USD 200 million FY28 CrudeChem guidance dependent on crude oil prices or backed by order book? Would sub-USD 60 crude push back targets? (Parth Modi, Equirus Securities)
- Answer: Guidance is order book– and customer engagement–driven, not crude-linked. Higher crude supports US activity, but production investments are planned 2+ years ahead, so activity continues even at lower prices; USD 60–100 range does not change the outlook. (Sanjay Tibrewala)
CrudeChem Margins & India Standalone Dip
- Question: Is utilization 63% of 148,000 or 80,000 MTPA? What are CrudeChem standalone margins? Is the standalone India revenue decline a concern? (Sunil Jain, Nirmal Bang Equities)
- Answer: 63% of 148,000 MTPA. Consolidated gross margin at 35.42% (vs 33% YoY, 29–30% last quarter); EBITDA margin 15.7%, up ~150 bps from 13.93% last quarter — implying CrudeChem EBITDA margins are at least 13–14%. India standalone dip is optical: new product lines manufactured under FSPL Specialties (100% subsidiary, 115BAB 15% tax regime); combined FCL + FSPL shows no decline. (Sanjay Tibrewala)
Consolidation Mechanics & Margin Path to 18%
- Question: Since Fineotex owns 53% of CrudeChem, will only ~USD 50 million of USD 100 million reflect in consolidated revenue? How do we get from 16% to 18% EBITDA margins? (Utkarsh Somaiya, Eiko Quantum Solutions)
- Answer: Full consolidation applies under Ind AS given controlling stake — entire revenue (₹250 crores/quarter ≈ USD 100 million annualized) is consolidated; NCI details are in published results. Margins: no fixed blended margin guidance possible in a 100+ product basket; customer engagements and long-term leadership matter more, though management will always aspire to improve EBITDA margins. (Sanjay Tibrewala)
Textile Business Decline & ROCE Profile
- Question: Consolidated revenue minus CCTL (~₹245 crores) implies textile at ₹132 crores vs ₹137 crores Q1 FY26 — why the dip? Will USD 200 million CrudeChem target require more capex at 65% utilization? What is the ROCE profile? (Prateek Giri, Subhlabh Research)
- Answer: Textile dip is 1–2%, normal Q1 monsoon seasonality and competitive pressure; expectations are for improvement — Bangladesh technical/marketing team expanded, Bharat Tex generated opportunities, more international exhibitions planned. Utilization is one-shift based; two shifts can be added, incremental capex is only USD 1–2 million. ROCE/ROE are best-in-industry — specialty chemicals are not capex-driven; focus is on winning business from global majors (Shell, Exxon). (Sanjay Tibrewala)
Customer Behavior & Wallet Share Post-Acquisition
- Question: Are CCT's large customers changing behavior given Fineotex backing? Any wallet-share gain anecdotes? (Prateek Giri, Subhlabh Research)
- Answer: "Powered by Fineotex" gives service operators confidence on volumes and investment capacity; multiple factors driving gains — production and R&D investment, doctorates joining US team, faster execution, raw material procurement at better prices, cross-selling with common customers, and offering Asia-made products (India/Malaysia) to US customers. (Sanjay Tibrewala)
Synergies Quantified & Order Book
- Question: Can you quantify operational synergies/efficiencies from CCT? What is the current order book and average order value? (Samarth Goel, Choice Institutional Equities)
- Answer: Synergies span technology transfer, customer handling, cross-selling, green chemistry portfolio expansion, and better supplier pricing from capital infusion — all contributing to EBITDA margin expansion. Oil & gas has no traditional order book; demand is well-driven with small cycles (weather interruptions), and business is "perennial" once wells are producing. ESG credentials (Dun & Bradstreet badge) are increasingly a competitive differentiator. (Sanjay Tibrewala)
CrudeChem Growth vs Market CAGR & Margin Details
- Question: End market is growing 5–7% CAGR — what will be done differently to reach USD 200 million? What was CCT-specific margin in Q1? Any textile growth guidance? (Rushil Shah, Molecule Ventures)
- Answer: CrudeChem has already doubled from historical levels despite similar market growth; sustainability tailwind, references with biggest service providers, and "me-too snowball effect" are driving replication; two years remain to reach USD 200 million. CCT margins implied at 13–14% within the 15.7% blended (which includes lower-margin legacy business). Textile: "auto-run" business, 30%+ CAGR historically from 2011–2022/23; content with current trajectory despite industry headwinds. (Sanjay Tibrewala)
Dealer Growth, Export Mix & Trackmax Logistics
- Question: Are the 103→115 new dealers from FCL or CCT? Is export mix shift (70%→77%) due to CrudeChem? Should the Trackmax last-mile logistics/telematics business be divested? (Rohit Ohri, Progressive Shares)
- Answer: Dealers are primarily Fineotex India standalone — CCT sells direct to end users/service operators. Export classification captures all non-India sales including Malaysia and USA. Trackmax is intrinsic to the US service model — customers pay premium for door-step delivery, insurance and reliability; it is held in a separate entity to isolate litigation/insurance risk and adds sustainable, competitive value; it will not be divested. (Sanjay Tibrewala)
Margin Sustainability & War Impact
- Question: Are the last two quarters' strong margins a one-off from war-driven chemical price spikes, or sustainable? Can 18% margin trajectory be maintained? (Hardik, Lark)
- Answer: Margins are sustainable — the company is not a trader holding inventory for price gains; it is a solutions provider with pass-through pricing and well-defined US "war surcharge"/fuel surcharge mechanisms that both suppliers and customers accept. The situation is now "new normal" and embedded in customer expectations; no single product price answer given a multi-product, multi-factor model. (Sanjay Tibrewala)
Geographic Expansion — North America & Middle East
- Question: Are we targeting customers close to Texas (Chevron, ConocoPhillips) and Gulf markets beyond the big names? (Akhilesh Pathak, Smart Sync Services)
- Answer: Those names were examples; Canada sales began last month and are progressing well; Suriname and Guyana (US-linked hardcore oil-producing countries) present plant-setup opportunities with service operators. A Saudi order was recently won after two years of R&D — the customer secured a USD 8 billion Aramco order that will use Fineotex specialty packages (5–6 product line combination), competing successfully against top US specialty chemical companies on pricing with equivalent performance. (Sanjay Tibrewala)
Key Takeaway
Fineotex delivered a transformative Q1 FY27 with total income of ₹386.72 crores (+165% YoY) and PAT of ₹48.21 crores (+92.67% YoY), driven primarily by the full-quarter consolidation of the CrudeChem US oilfield chemicals business, which now contributes 65% of revenue (₹250 crores) and underpins management's USD 100 million FY27 / USD 200 million FY28 oil & gas guidance. The newly commissioned Texas capacity expansion to 148,000 MTPA (total 268,000 MTPA) is running at 63% utilization on one shift, giving 30–40% near-term revenue headroom with minimal incremental capex, while consolidated EBITDA margins expanded ~150 bps QoQ to 15.70% on integration synergies — technology transfer, procurement leverage, green chemistry, and Trackmax last-mile delivery. The textile business remained flattish on monsoon seasonality and competition, with recovery expected via Bangladesh expansion and trade fair wins; the India standalone dip is attributed to the FSPL Specialties transfer under the 115BAB tax regime. Strategy centers on disciplined M&A (synergy-plus-value criteria), cross-selling across global customers, and geographic expansion into Canada, the Middle East (Aramco-linked packages), and Suriname/Guyana. Watch points include Middle East-driven raw material volatility, US capacity ramp-up pace, and Indian textile competitive intensity, with management framing Q1 FY27 as the base quarter for sustained growth ahead.